GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CEO Buys Highlight: KMI, VRX, CLMS, OPK, TLOG

December 23, 2013 | About:
hyperman299

GuruFocus

349 followers

According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:

Kinder Morgan Inc. (KMI): Chairman and CEO, 10% Owner Richard D. Kinder Bought 828,324 Shares

Chairman and CEO, 10% Owner of Kinder Morgan Inc. (KMI) Richard D. Kinder bought 828,324 shares on 12/18/2013 at an average price of $35.22. Kinder Morgan Inc. was formed in Delaware in August 1992. Kinder Morgan Inc. has a market cap of $36.48 billion; its shares were traded at around $35.22 with a P/E ratio of 39.20 and P/S ratio of 3.22. The dividend yield of Kinder Morgan, Inc. stocks is 4.43%.Mario Gabelli owns 221,703 shares as of 09/30/2013, which accounts for 0.046% of the $17.03 billion portfolio of GAMCO Investors. Steve Mandel owns 10,913,487 shares as of 09/30/2013, which accounts for 1.7% of the $22.4 billion portfolio of Lone Pine Capital. John Burbank owns 28,000 shares as of 09/30/2013, a decrease of 98.96% of from the previous quarter. This position accounts for 0.032% of the $3.09 billion portfolio of Passport Capital.VP, HR and Administration James E. Street bought 985 shares of KMI stock on 12/04/2013 at the average price of 33.21. James E. Street owns at least 2,071,304 shares after this. The price of the stock has increased by 6.05% since. Other insiders have also increased their positions in the company. 

Valeant Pharmaceuticals International Inc. (VRX): CEO J. Michael Pearson Bought 184,247 Shares

CEO of Valeant Pharmaceuticals International Inc. (VRX) J. Michael Pearson bought 184,247 shares on 12/14/2013 at an average price of $112.00. Valeant Pharmaceuticals International Inc. was formerly known as Biovail Corporation. Valeant Pharmaceuticals International Inc. has a market cap of $37.29 billion; its shares were traded at around $112.00 with and P/S ratio of 7.56.

Valeant Pharmaceuticals International Inc. had an annual average earnings growth of 0.20% over the past 10 years.Valeant Pharmaceuticals recently reported its third quarter 2013 financial results. Total revenue for the quarter was $1.54 billion, an increase of 74% over the prior year.

Jeff Ubben owns 18,923,877 shares as of 09/30/2013, which accounts for 17.8% of the $11.08 billion portfolio of ValueAct Capital. Lou Simpson owns 1,660,917 shares as of 09/30/2013, which accounts for 9.3% of the $1.87 billion portfolio of SQ Advisors LLC. Ruane Cunniff owns 34,647,147 shares as of 09/30/2013, which accounts for 21.5% of the $16.85 billion portfolio of Ruane & Cunniff & Goldfarb. Lee Ainslie sold out his holdings in the quarter that ended on 09/30/2013.Senior Officer Laizer Kornwasser, bought 3,500 shares of VRX stock on 11/18/2013 at the average price of $107.38. Laizer Kornwasser, owns at least 10,000 shares after this. The price of the stock has increased by 4.3% since.

Calamos Asset Management Inc. (CLMS): Chairman, CEO, Global Co-CIO, 10% Owner John P. Calamos Sr. Bought 199,644 Shares

Chairman, CEO, Global Co-CIO, 10% Owner of Calamos Asset Management Inc. (CLMS) John P. Calamos Sr. bought 199,644 shares during the past week at an average price of $11.50. Calamos Asset Management Inc., is a global asset management firm that offers strategies to fulfill a range of asset allocation goals through a multi-team platform. Calamos Asset Management Inc. has a market cap of $237.335 million; its shares were traded at around $11.50 with a P/E ratio of 19.20 and P/S ratio of 0.85. The dividend yield of Calamos Asset Management Inc. stocks is 4.33%.

Calamos recently reported its third quarter 2013 financial results. Non-GAAP diluted earnings per share was $0.20 for the third quarter compared to $0.22 in the previous quarter. Non-GAAP net income attributable to Calamos Asset Management Inc. was $4.1 million for the quarter compared to $4.5 million last quarter.Mario Gabelli owns 126,000 shares as of 09/30/2013, which accounts for 0.0074% of the $17.03 billion portfolio of GAMCO Investors. SVP and CFO Nimish S. Bhatt bought 364 shares of CLMS stock on 11/20/2013 at the average price of $10.47. Nimish S. Bhatt owns at least 90,543 shares after this. The price of the stock has increased by 9.84% since.

Opko Health Inc. (OPK): CEO and Chairman, 10% Owner Phillip Frost Md. Et Al Bought 233,900 Shares

CEO and Chairman, 10% Owner of Opko Health Inc. (OPK) Phillip Frost Md. Et Al bought 233,900 shares during the past week at an average price of $9.01. Opko Health Inc. was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. Opko Health Inc. has a market cap of $3.68 billion; its shares were traded at around $9.01 with and P/S ratio of 31.07.Opko recently reported its third quarter 2013 financial results. Revenue nearly doubled to $20.6 million for the third quarter of 2013, and increased more than twofold to $75.8 million for the first nine months of 2013.

George Soros bought 745,000 shares in the quarter that ended on 09/30/2013, which is 0.072% of the $9.14 billion portfolio of Soros Fund Management LLC. Mario Gabelli owns 15,000 shares as of 09/30/2013, which accounts for 0.0008% of the $17.03 billion portfolio of GAMCO Investors.

TetraLogic Pharmaceuticals Corporation (TLOG): President and CEO J. Kevin Buchi Bought 285,714 Shares

President and CEO of TetraLogic Pharmaceuticals Corporation (TLOG) J. Kevin Buchi bought 285,714 shares on 12/17/2013 at an average price of $7.59. Tetralogic Pharmaceuticals Corporation has a market cap of $160.277 million; its shares were traded at around $7.59. CFO and Treasurer Peter A. Meyers bought 142,857 shares of TLOG stock on 12/17/2013 at the average price of $7. Peter A. Meyers owns at least 142,857 shares after this. The price of the stock has increased by 8.43% since.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK